The siRNA ‐mediated downregulation of PD‐1 alone or simultaneously with CTLA‐4 shows enhanced in vitro CAR‐T‐cell functionality for further clinical development towards the potential use in immunotherapy of melanoma

Experimental Dermatology,Volume 27, Issue 7, Page 769-778, July 2018.

Source: Experimental Dermatology - June 28, 2018 Category: Dermatology Authors: Bianca Simon , Dennis C. Harrer , Beatrice Schuler ‐Thurner , Niels Schaft , Gerold Schuler , Jan Dörrie , Ugur Uslu Source Type: research